HRMY
Harmony Biosciences Holdings (HRMY)
$28
About Harmony Biosciences Holdings (HRMY)
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Details
Daily high
$34.97
Daily low
$33.48
Price at open
$33.48
52 Week High
$41.61
52 Week Low
$28.14
Market cap
2.0B
Dividend yield
0.00%
Volume
3.0M
Avg. volume
608,038
P/E ratio
16.23
Harmony Biosciences Holdings News
Details
Daily high
$34.97
Daily low
$33.48
Price at open
$33.48
52 Week High
$41.61
52 Week Low
$28.14
Market cap
2.0B
Dividend yield
0.00%
Volume
3.0M
Avg. volume
608,038
P/E ratio
16.23